Benzocaine-Induced Methemoglobinemia Based on the Mayo Clinic Experience From 28 478 Transesophageal Echocardiograms | Zendy

Garvan C. Kane | Zendy; Suzette M. Hoehn | Zendy; Thomas Behrenbeck | Zendy; Sharon L. Mulvagh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Benzocaine-Induced Methemoglobinemia Based on the Mayo Clinic Experience From 28 478 Transesophageal Echocardiograms

Author(s) -

Garvan C. Kane,

Suzette M. Hoehn,

Thomas Behrenbeck,

Sharon L. Mulvagh

Publication year - 2007

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.167.18.1977

Subject(s) - methemoglobinemia , medicine , benzocaine , methemoglobin , anesthesia , sedation , midazolam , incidence (geometry) , cohort , surgery , hemoglobin , physics , optics

The potentially life-threatening condition of methemoglobinemia is characterized by cyanosis, low pulse oximetric readings, and normal arterial Po(2) values. Acquired methemoglobinemia has been linked to the use of the topical anesthetic benzocaine in endoscopic procedures, including transesophageal echocardiography (TEE). Yet, the incidence of benzocaine-induced methemoglobinemia with TEE and the clinical factors associated with its development are unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research